posted on 2022-06-28, 00:15authored bySC Faville, K Harris-Hamdscomb, O Harker, S Mattison, H Tamorite, J Bristowe, D Daly, R Ege, H He, J Jones, A McCorkindale, K Mei, A Monson, L Moree, F Perkovic, G Rickerby, J Robinson, F Rudkin, L Whibley, R Worthington, Courtney EnnisCourtney Ennis, S De La Harpe, T Brind, A Hopkins, K Winefield, S Hendrickx, G Caljon, B Perry, AJ Vernall
An undergraduate laboratory was developed as part of the Drugs for Neglected Diseases initiative's Open Synthesis Network. This activity aimed to develop new compounds efficacious against visceral leishmaniasis. Students successfully synthesized, purified, and characterized ten different benzoxazole amides that were sent for biological testing against several protozoan parasites. Although all the benzoxazole amides had poor activity against L. donovani, several (2, 4, and 9) showed moderate activity against T. cruzi, T. b. rhodesiense, and T. b. brucei paired with low cell cytotoxicity. This drug discovery laboratory activity made a measurable contribution to neglected tropical disease research and was an engaging and research-orientated experience for undergraduate students. Implementation of drug discovery laboratories across a range of student levels and backgrounds is highly achievable using existing laboratory equipment and a short investment in activity preparation and can be a sustainable course component.
Funding
We thank the Department of Chemistry, University of Otago for funding the chemicals for this project as an Undergraduate Lab. DNDi is grateful to the French Development Agency (AFD), France for funding the OSN, and to the following donors for contributing to DNDi's overall mission: UK aid, UK; Medecins Sans Frontie`res, International; and the Swiss Agency for Development and Cooperation (SDC), Switzerland.
History
Publication Date
2022-04-12
Journal
Journal of Chemical Education
Volume
99
Issue
4
Pagination
9p. (p. 1682-1690)
Publisher
American Chemical Society and Division of Chemical Education, Inc.